Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices
Back to the NewsWire

KMPH

Published November 13, 2026 · Updated November 14, 2026

US offers up to $4.9 million to prepare PTSD studies of controversial psychedelic drug

Read the full story at KMPH

psychedelic that advocates say may help treat post-traumatic stress disorder ... NEWS IN PHOTOS: "Local". Image for gallery: Crime Stoppers Daily Most.

Surfaced by 2 Google Alerts

  • Psychedelic crime
  • Psychedelics south america